Status:

COMPLETED

Assessment of Unilateral Lymphoedema of the Leg

Lead Sponsor:

ImpediMed Limited

Conditions:

Lymphedema

Eligibility:

All Genders

18-75 years

Brief Summary

To demonstrate that ImpediMed L-Dex U400 can be used to assess unilateral Lymphoedema of the leg using the same principles for arms.

Detailed Description

When Lymphoedema is present, lymph and other fluids build up in the interstitial spaces of the tissues. This results in an overall increase in the total amount of extracellular fluid (ECF) in the limb...

Eligibility Criteria

Inclusion

  • Group 1:
  • Be between the ages of 18-75 years.
  • Self-describe general health as satisfactory.
  • Understand the proposed study and be willing and fully able to comply with the study procedures.
  • Be a willing participant and be capable of giving and has given informed written consent for entry into the study.
  • Have been previously diagnosed, by current clinical practice, as having unilateral Lymphoedema of the leg.
  • Group 2:
  • Be between the ages of 18-75 years.
  • Self-describe general health as satisfactory.
  • Understand the proposed study and be willing and fully able to comply with the study procedures.
  • Be a willing participant and be capable of giving and has given informed written consent for entry into the study.

Exclusion

  • Have a known heart condition or an implantable device such as a pacemaker or ICD.
  • Have a metallic surgical implant (e.g. total hip replacement) not including small implants such as sternal wires or surgical staples.
  • Suffer from a renal disorder.
  • Be taking diuretic medications.
  • Have consumed large amounts of alcohol or caffeinated beverages within six hours of the study.
  • Have undertaken excessive exercise within two hours of BIA
  • Have a reported fever of \> 38°C at time of screening.
  • Be currently in the fourth week of the menstrual cycle.
  • Be pregnant or currently breastfeeding.

Key Trial Info

Start Date :

August 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 1 2009

Estimated Enrollment :

45 Patients enrolled

Trial Details

Trial ID

NCT00757406

Start Date

August 1 2008

End Date

January 1 2009

Last Update

April 16 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Qld Lymphoedema and Breast Oncology Physiotherapy

Brisbane, Queensland, Australia, 4051

Assessment of Unilateral Lymphoedema of the Leg | DecenTrialz